TARS logo

Tarsus Pharmaceuticals (TARS) Working capital

annual working capital:

$276.09M+$56.90M(+25.96%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TARS annual working capital is $276.09 million, with the most recent change of +$56.90 million (+25.96%) on December 31, 2024.
  • During the last 3 years, TARS annual working capital has risen by +$111.62 million (+67.86%).
  • TARS annual working capital is now at all-time high.

Performance

TARS Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

quarterly working capital:

$394.46M+$118.37M(+42.87%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TARS quarterly working capital is $394.46 million, with the most recent change of +$118.37 million (+42.87%) on March 31, 2025.
  • Over the past year, TARS quarterly working capital has increased by +$96.27 million (+32.28%).
  • TARS quarterly working capital is now at all-time high.

Performance

TARS quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

TARS Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+26.0%+32.3%
3 y3 years+67.9%+137.4%
5 y5 years+382.6%-

TARS Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+67.9%at high+133.8%
5 y5-yearat high+382.6%at high+664.0%
alltimeall timeat high>+9999.0%at high+664.0%

TARS Working capital History

DateAnnualQuarterly
Mar 2025
-
$394.46M(+42.9%)
Dec 2024
$276.09M(+26.0%)
$276.09M(-5.2%)
Sep 2024
-
$291.25M(-6.4%)
Jun 2024
-
$311.02M(+4.3%)
Mar 2024
-
$298.20M(+36.0%)
Dec 2023
$219.19M(+4.4%)
$219.19M(-7.1%)
Sep 2023
-
$236.03M(+39.9%)
Jun 2023
-
$168.71M(-13.7%)
Mar 2023
-
$195.39M(-6.9%)
Dec 2022
$209.95M
$209.95M(-4.5%)
Sep 2022
-
$219.81M(-7.9%)
DateAnnualQuarterly
Jun 2022
-
$238.56M(+43.6%)
Mar 2022
-
$166.15M(+1.0%)
Dec 2021
$164.47M(-0.5%)
$164.47M(-6.9%)
Sep 2021
-
$176.72M(-7.2%)
Jun 2021
-
$190.45M(+5.0%)
Mar 2021
-
$181.33M(+9.7%)
Dec 2020
$165.27M(+188.9%)
$165.27M(+99.3%)
Sep 2020
-
$82.93M(+60.6%)
Jun 2020
-
$51.63M(-9.8%)
Dec 2019
$57.21M(+2495.8%)
$57.21M
Dec 2018
$2.20M
-

FAQ

  • What is Tarsus Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual working capital year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly working capital year-on-year change?

What is Tarsus Pharmaceuticals annual working capital?

The current annual working capital of TARS is $276.09M

What is the all time high annual working capital for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual working capital is $276.09M

What is Tarsus Pharmaceuticals annual working capital year-on-year change?

Over the past year, TARS annual working capital has changed by +$56.90M (+25.96%)

What is Tarsus Pharmaceuticals quarterly working capital?

The current quarterly working capital of TARS is $394.46M

What is the all time high quarterly working capital for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly working capital is $394.46M

What is Tarsus Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, TARS quarterly working capital has changed by +$96.27M (+32.28%)
On this page